Evidence map›Paper›PMID 28955983›Full record

ArticleBiochemistry and biophysics reports2017

On mechanism of antioxidant effect of fullerenols.

A S Sachkova, E S Kovel, G N Churilov, O A Guseynov, A A Bondar, I A Dubinina, N S Kudryasheva

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Toxicity and Antioxidant Activity of Fullerenol CInternational journal of molecular sciences · 2021
    Article
  9. Effects of Aqueous Dispersions of CInternational journal of molecular sciences · 2021
    Article
  10. Antioxidant Potential of Aqueous Dispersions of Fullerenes CInternational journal of molecular sciences · 2021
    Article
  11. Article
  12. Fullerol CToxins · 2020
    Article
  13. A Multiparametric Study of Internalization of Fullerenol CInternational journal of molecular sciences · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Fullerol CScientific reports · 2018
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

A S SachkovaNational Research Tomsk Polytechnic University, Tomsk 634050, Russia.
E S KovelInstitute of Biophysics SB RAS, Krasnoyarsk 660036, Russia.
G N ChurilovInstitute of Physics SB RAS, Krasnoyarsk 660036, Russia.
O A GuseynovSiberian Federal University, Krasnoyarsk 660041, Russia.
A A BondarSB RAS Genomics Core Facility, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk 630090, Russia.
I A DubininaInstitute of Physics SB RAS, Krasnoyarsk 660036, Russia.
N S KudryashevaInstitute of Biophysics SB RAS, Krasnoyarsk 660036, Russia.
Institute of Physics · RUSiberian Federal University · RUInstitute of Biophysics · RUInstitute of Chemical Biology and Fundamental Medicine · RUNational Research Tomsk State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fullerenols are nanosized water-soluble polyhydroxylated derivatives of fullerenes, specific allotropic form of carbon, bioactive compounds and perspective pharmaceutical agents. Antioxidant activity of fullerenols was studied in model solutions of organic and inorganic toxicants of oxidative type - 1,4-benzoquinone and potassium ferricyanide. Two fullerenol preparations were tested: С

Indexed as

Antioxidant activityBacterial enzymesF-60, 70, mixture of fullerenols С60О2–4(ОН)20–24 and С70О2–4(ОН)20–24F-60, fullerenol С60О2–4(ОН)20–24;FMN, flavinmononucleotideFullerenolGT, general toxicityHormesisLuminous marine bacteriaNADH, nicotinamide adenine dinucleotide disodium salt reducedOxT, oxidative toxicityUltralow concentrations

Identifiers

PMID28955983
PMCPMC5614482
OpenAlexW2551982796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.